Discontinuation report ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS
Report ID | 88139 |
Drug Identification Number | 02154234 |
Brand name | ACETAMINOPHEN 300 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE |
Common or Proper name | Acetaminophen 300 mg with 15 mg Caffeine and 8 mg Codeine Phosphate |
Company Name | LABORATOIRE RIVA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ACETAMINOPHEN CODEINE PHOSPHATE CAFFEINE |
Strength(s) | 300MG 8MG 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30, 50, 100, 200 |
ATC code | N02AJ |
ATC description | OPIOIDS |
Reason for discontinuation | Other (Please describe in comments) |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-06-29 |
Remaining supply date | 2019-06-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | No remaining supply. |
Company comments | Not commercially viable. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 660 BOUL. INDUSTRIEL BLAINVILLE, QUEBEC CANADA J7C 3V4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-02 | English | Compare |
v2 | 2019-07-02 | English | Compare |
v3 | 2019-07-02 | French | Compare |
v4 | 2019-07-02 | English | Compare |
v5 | 2019-07-02 | French | Compare |
Showing 1 to 5 of 5